Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -86687.50% is 3150% below its 5-year average of -2666.93%, near the low end of its 5-year range (-86687.50%–61.56%).
824.77% below its 12-month average of -9373.96%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1248.96%.
NET PROFIT MARGIN
-86687.50%
NET PROFIT MARGIN AVG TTM
-9373.96%
NET PROFIT MARGIN AVG 3Y
-4190.89%
NET PROFIT MARGIN AVG 5Y
-2666.93%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-824.77%
CURRENT VS 3Y AVG
-1968.47%
CURRENT VS 5Y AVG
-3150.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 627 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Connect Biopharma Holdings Limited
Market Cap
$57.49M
Net Profit Margin
-86687.50%
TTM Avg
-9373.96%
3Y Avg
-4190.89%
5Y Avg
-2666.93%
Market Cap
$56.78M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$57.54M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$58.22M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$54.90M
Net Profit Margin
-69.27%
TTM Avg
-45.15%
3Y Avg
-54.32%
5Y Avg
-40.58%
Market Cap
$59.36M
Net Profit Margin
0.00%
TTM Avg
-36932.26%
3Y Avg
-34526.76%
5Y Avg
-23017.84%
Market Cap
$53.81M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$53.69M
Net Profit Margin
-5668.62%
TTM Avg
-3356.71%
3Y Avg
-1974.47%
5Y Avg
-1414.89%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $57.49M | -86687.50% | -9373.96% | -4190.89% | -2666.93% |
| OKYO Pharma Limited (OKYO)vs › | $56.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aldeyra The (ALDX)vs › | $56.64M | 0.00% | 0.00% | 0.00% | 0.00% |
| Boundless Bio, Inc. (BOLD)vs › | $57.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Oncolytics Biotech Inc. (ONCY)vs › | $58.22M | 0.00% | 0.00% | 0.00% | 0.00% |
| Spectral AI, Inc. (MDAI)vs › | $54.90M | -69.27% | -45.15% | -54.32% | -40.58% |
| Fractyl Health, Inc. (GUTS)vs › | $59.36M | 0.00% | -36932.26% | -34526.76% | -23017.84% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $53.81M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImageneBio Inc (IMA)vs › | $53.69M | -5668.62% | -3356.71% | -1974.47% | -1414.89% |
| eXoZymes, Inc. (EXOZ)vs › | $53.09M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-90740.6%
Net Profit Margin
-86687.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1248.96% |
| 2025-12-31 | 0.00% |
| 2025-06-30 | -26872.92% |
| 2024-12-31 | -1275.93% |
| 2024-06-30 | 61.56% |
| 2023-12-31 | 0.00% |
| 2023-06-30 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-06-30 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-06-30 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-06-30 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-06-30 | 0.00% |
| 2018-12-31 | 0.00% |